Catalogue Search | MBRL
Are you sure you want to remove the book from the shelf?
{{itemTitle}}
135,787
result(s) for
"Legalization"
Sort by:
RETRACTED ARTICLE: Banning the purchase of sex increases cases of rape: evidence from Sweden
This paper leverages the timing of a ban on the purchase of sex to assess its impact on rape offenses. Relying on Swedish high-frequency data from 1997 to 2014, I find that the ban increases the number of rapes by around 44–62%. The results are robust to several econometric specifications that exploit different identification assumptions. The increase reflects a boost in completed rapes both in the short- and long-run. However, it is not accompanied by a decrease in the number of pimps. Taken together, the empirical evidence hints at the notion that the rise in rapes is not connected to the supply of prostitution but rather to changes in the demand for prostitution due to the ban. The results here have the opposite sign but larger magnitudes in absolute value than results in the literature on the decriminalization of prostitution.
Journal Article
War on the Weak
A CASE STUDY in brain-dead deconsolidation: A marijuana legalization. According to the 2023 National Survey on Drug Use and Health, more than a fifth of blacks 18 to 25 suffer from the disorder. According to the New York Office of Addiction Services, black adults constitute 37 percent of admissions to marijuana treatment programs, although blacks represent 18 percent of the states population.
Journal Article
Medical Marijuana Laws Reduce Prescription Medication Use In Medicare Part D
Legalization of medical marijuana has been one of the most controversial areas of state policy change over the past twenty years. However, little is known about whether medical marijuana is being used clinically to any significant degree. Using data on all prescriptions filled by Medicare Part D enrollees from 2010 to 2013, we found that the use of prescription drugs for which marijuana could serve as a clinical alternative fell significantly, once a medical marijuana law was implemented. National overall reductions in Medicare program and enrollee spending when states implemented medical marijuana laws were estimated to be $165.2 million per year in 2013. The availability of medical marijuana has a significant effect on prescribing patterns and spending in Medicare Part D.
Journal Article
An overview of select cannabis use and supply indicators pre- and post-legalization in Canada
Background
Canada implemented the legalization and regulation of non-medical cannabis use, production and sale in 2018 aiming to improve public health and safety. While outcomes from legalization reforms in other jurisdictions mostly rely on US-based data have been assessed to be mixed, Canadian data are only emerging. We compiled select population-level data on key indicators to gauge initial developments from pre- to post-legalization of cannabis in Canada.
Methods
We examined indicators data focusing on the following topics: prevalence of cannabis use, frequency of use, methods/products of consumption, driving after cannabis use, and cannabis sourcing. Indicator data were obtained mostly from national and some provincial population surveys. Prevalence or percentages for the indicators pre- and post-legalization (e.g., 2017- 2020), including confidence intervals were reported, with changes noted, as available in and indicated by the data sources.
Results
Data suggested selected increases in cannabis use prevalence, mostly among mid- and older- but possibly also younger (e.g., under legal use age) users. Frequency of use and driving after cannabis use among active users do not appear to have changed. Methods of cannabis use show diversifying trends, with decreases in smoking and increases in alternatives use modes (e.g., edibles, vaping). There is a clearly increasing trend towards accessing cannabis from legal sources among adults, while under-legal-use-age youth do not appear to experience heightened barriers to obtaining cannabis in legalization contexts.
Conclusions
Preliminary indicators on cannabis legalization in Canada show a mixed picture, some similar to US-based developments. While some use increases are observed, these do not necessarily represent indications of increases in cannabis-related harm, also since key (e.g., hospitalization or injury) data are lacking to date. There is a gradual embracing of legal supply sources of cannabis among users, which can be expected to serve public health and safety objectives. At the same time, cannabis use and access among under-age users as a principally vulnerable group do not appear to be hindered or reduced by legalization.
Journal Article
Recreational Cannabis Legalization and Opioid-Related Deaths in Colorado, 2000–2015
Objectives. To examine the association between Colorado’s legalization of recreational cannabis use and opioid-related deaths. Methods. We used an interrupted time-series design (2000–2015) to compare changes in level and slope of monthly opioid-related deaths before and after Colorado stores began selling recreational cannabis. We also describe the percent change in opioid-related deaths by comparing the unadjusted model-smoothed number of deaths at the end of follow-up with the number of deaths just prior to legalization. Results. Colorado’s legalization of recreational cannabis sales and use resulted in a 0.7 deaths per month (b = −0.68; 95% confidence interval = −1.34, −0.03) reduction in opioid-related deaths. This reduction represents a reversal of the upward trend in opioid-related deaths in Colorado. Conclusions. Legalization of cannabis in Colorado was associated with short-term reductions in opioid-related deaths. As additional data become available, research should replicate these analyses in other states with legal recreational cannabis.
Journal Article
Is legalization of recreational cannabis associated with levels of use and cannabis use disorder among youth in the United States? A rapid systematic review
Cannabis legalization policies are rapidly changing in the United States. While there are concerns that recreational legalization will negatively affect young people, previous reviews have not provided clear indication of such effects. The purpose of this rapid systematic review was to examine whether recreational legalization was associated with increases in prevalence of cannabis use and use disorder among adolescents and young adults. PubMed/MEDLINE, Embase, Scopus, PsycInfo, Web of Science, Dissertations & Theses Global, the Trip Database, and OpenGrey were searched from date of inception through Marcy 17, 2022 to retrieve all relevant records. English language and human subject filters were applied. Two reviewers screened abstracts and titles, assessed full text articles, and coded the final included articles. Studies including primarily 10- to 19–year-olds were classified as adolescent, and those between 18 and 26 years as young adult. Our search identified 33 research reports (22 with adolescent samples; 14 young adult). For adolescents, ten studies reported no change in use prevalence associated with legalization, six reported a decrease, and seven reported an increase. Among young adults, most studies (8) showed an increase in at least one prevalence measure, four showed no change, and one showed a decrease. Only two adolescent and one young adult study examined cannabis use disorder, both adolescent studies showed an increase, and the young adult showed no change. The majority of studies had risk of bias. Recreational legalization may be associated with increases in prevalence of cannabis use in young adults while results for adolescents are mixed. Policymakers and practitioners should consider appropriate prevention and treatment options for young people.Trial Registration: PROSPERO #CRD42021276984.
Journal Article
International Perspectives on the Implications of Cannabis Legalization: A Systematic Review & Thematic Analysis
The legality, recreational and medical use of cannabis varies widely by country and region but remains largely prohibited internationally. In October 2018, Canada legalized the recreational use of cannabis—a move many viewed as controversial. Proponents of legalization have emphasized the potential to eradicate the marijuana black market, improve quality and safety control, increase tax revenues, improve the availability of medical cannabis, and lower gang-related drug violence. Conversely, opponents of legalization have stressed concerns about cannabis’ addictive potential, second-hand cannabis exposure, potential exacerbation of underlying and established mental illnesses, as well as alterations in perception that affect safety, particularly driving. This systematic review synthesizes recent international literature on the clinical and public health implications of cannabis legalization.
Journal Article
Outcomes associated with nonmedical cannabis legalization policy in Canada: taking stock at the 5-year mark
In Oct 2018, the recreational use of cannabis was legalized in Canada with the primary objectives of improving cannabis-related public health and safety, reducing youth access to cannabis, and reducing cannabis-related crime and illegal markets. Five years after policy implementation, available evidence suggests that outcomes related to health-such as the prevalence of cannabis use, cannabis-related emergency department visits and admissions to hospital and cannabis impaired driving-have mostly increased or remained steady. Substantial reductions in criminal arrests and charges related to cannabis use-and related stigma and other personal burdens-among both adults and youth should be noted as related positive social justice and possibly indirect public health outcomes. Continued measurement of key health and social outcomes, as well as robust ways to integrate diverse data when evaluating policy outcomes, are needed to inform evidence-based adjustments to regulatory parameters that will more effectively serve the declared public health objectives of cannabis legalization in Canada.
Journal Article